glp 1 for mental health Reassuring' findings suggest GLP-1 receptor agonists do not increase suicide risk GLP-1 medications used to treat
Description
9 , e57e62 (2012)
JMIR Formative Research
By February 2025 for semaglutide and March 2025 for tirzepatide, FDA declared both shortages resolved and transitional exemption windows ended
Second, the lack of characterized liver tests/ultrasonography in the patient population precludes the evaluation of obesity-related liver complications
Digital Brain (@yourdigitalbrain.bsky.social) May 1, 2026 at 4:11 PM The study of the effectiveness, potential health risks, large-scale benefit and long-term effects of GLP-1s is a field that will be turning out regular findings for decades to come, given the millions, and perhaps billions of people worldwide interested in weight loss for one reason or the other
It also reduced the body weight by up to 6.5 kg from baseline
